According to filings with the U.S. Securities and Exchange Commission, Cardio Flow is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Kallok played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cardio Flow
Cardio Flows FreedomFlow is an atherectomy device that can remove arterial plaque that can block blood flow to parts of the body. There are five minimally invasive techniques for removing this plaque, but current devices on the market do not remove it as efficiently as physicians may prefer. This is especially the case for mineralized calcium deposits and blockages in large-diameter vessels above the knee, such as in the common femoral artery in the thigh and the common iliac and external iliac arteries in the pelvis. The ability to treat these larger vessels is important because they provide access to smaller vessels down the leg but current devices on the market may not treat vessels above 5 mm in diameter effectively.

To learn more about Cardio Flow, visit http://cardioflow.net/
Company Linkedin Page: https://www.linkedin.com/company/cardioflow/

Contact:
Michael Kallok, Chief Executive Officer
651-253-1754
https://www.linkedin.com/in/michael-kallok-0421499/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.